45 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • ATA Creativity Global AACG gained 114.3% to close at $2.55.
  • Hoth Therapeutics, Inc. HOTH surged 85.7% to settle at $1.30 after the company announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ.
  • NexTier Oilfield Solutions Inc. NEX climbed 26.6% to settle at $4.90 on Tuesday after the company issued an operational update and guidance for the fourth quarter. The company said it expects Q4 revenue of $500-$510 million, reflecting a surge of more than 25% from Q3 2021.
  • NLS Pharmaceutics AG NLSP rose 26.1% to close at $1.50 after the company announced the USPTO granted the company U.S. Patent No. 11207271, entitled A Mazindol Ir/Sr Multilayer Tablet And Its Use For The Treatment Of Attention Deficit/Hyperactivity Disorder.
  • Reliance Global Group, Inc. RELI jumped 23% to settle at $9.32.
  • REE Automotive Ltd. REE gained 20.6% to close at $6.73.
  • Winc, Inc. WBEV gained 20% to close at $6.97.
  • Oragenics, Inc. OGEN climbed 18.4% to close at $0.56. The company reported in Form 4 filing that Director Robert Koski bought 1 million shares at an average price of $0.47 per share.
  • ReTo Eco-Solutions, Inc. RETO gained 18.4% to settle at $1.74 after the company announced it entered into an Equity Acquisition Agreement with Hainan REIT Mingde Investment Holding Co.
  • Arcadia Biosciences, Inc. RKDA rose 17.8% to close at $1.39 on continued momentum after the company was granted a notice of allowance for a US patent titled 'Wheat Having Resistance to Glyphosate Due to Alterations in 5-Enol-Pyruvylshikimate-3 Phosphate Synthase.'
  • NeuroBo Pharmaceuticals, Inc. NRBO jumped 16.7% to close at $1.54 after gaining around 10% on Monday.
  • Plus Therapeutics, Inc. PSTV surged 16.4% to close at $1.28 after the company announced it has met two significant milestones as it progresses toward cGMP manufacture of Rhenium-186 NanoLiposome.
  • eMagin Corporation EMAN gained 15.5% to settle at $1.64.
  • Agrify Corporation AGFY rose 15.3% to close at $11.14. Agrify announced Tuesday that it has inked a definitive agreement for its largest Agrify Total Turn-Key Solution partnership to date with Gold Leaf Florida LLC.
  • American Realty Investors, Inc. ARL surged 14.7% to close at $13.75.
  • New York City REIT, Inc. NYC gained 13.8% to settle at $12.29.
  • Immix Biopharma, Inc. IMMX shares rose 12.3% to close at $6.49 on continued momentum after the U.S. Food and Drug Administration granted Rare Pediatric Disease designation for IMX-110 for the treatment of rhabdomyosarcoma, a life-threatening form of pediatric cancer in children.
  • Ford Motor Company F climbed 11.7% to close at $24.31 after the company announced it plans to nearly double production of the F-150 Lightning all-electric truck.
  • TherapeuticsMD, Inc. TXMD gained 11.2% to close at $0.4376 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to menopause.
  • TD Holdings, Inc. GLG rose 11.1% to close at $0.4795.
  • Heritage Insurance Holdings, Inc. HRTG gained 10.9% to close at $6.53 after the company announced a $25 million buyback.
  • Reata Pharmaceuticals, Inc. RETA gained 9% to close at $29.79.
  • Aravive, Inc. ARAV gained 7.4% to close at $2.63.
  • iSpecimen Inc. ISPC shares gained 5.5% to close at $8.50 after Craig-Hallum initiated coverage on the stock with a Buy rating and $20 price target.


Check out these big penny stock gainers and losers

Losers

  • Gritstone bio, Inc. GRTS dipped 42.4% to close at $7.02 as the company shared data from the first cohort (10 µg dose) of the Phase 1 booster trial of self-amplifying mRNA (samRNA) COVID-19 vaccine.
  • Zhangmen Education Inc. ZME shares fell 38.1% to close at $2.80 on Tuesday.
  • AVROBIO, Inc. AVRO shares declined 36.6% to settle at $2.56 after the company reported it is shifting its portfolio priorities to focus on other clinical-stage programs and extending its cash runway into the first quarter of 2024. It is deprioritizing its Fabry disease program.
  • Heliogen, Inc. HLGN fell 24.1% to settle at $10.30 after declining around 13% on Monday.
  • Valneva SE VALN fell 22.6% to close at $39.47. Valneva, last month, said its COVID-19 vaccine candidate was efficient as a booster for people who had received the same shot as an initial vaccination.
  • iCAD, Inc. ICAD fell 21.4% to close at $5.88 after the company issued Q4 and FY21 sales guidance below estimates.
  • Jowell Global Ltd. JWEL fell 21.2% to close at $6.93 after dipping around 60% on Monday.
  • Genprex, Inc. GNPX fell 20.3% to close at $2.79. Genprex expanded gene therapy oncology pipeline to include small cell lung cancer.
  • uCloudlink Group Inc. UCL dipped 18.4% to settle at $3.10.
  • BlueCity Holdings Limited BLCT dropped 16.1% to close at $1.51. BlueCity recently announced it received an acquisition offer for the company at $3.70/share.
  • Nuverra Environmental Solutions, Inc. NES declined 15.2% to settle at $2.57.
  • Everspin Technologies, Inc. MRAM shares fell 14.9% to close at $10.86.
  • ShiftPixy, Inc. PIXY fell 14.4% to settle at $1.01.
  • Intra-Cellular Therapies, Inc. ITCI shares dropped 14.1% to settle at $44.68 after the company reported a $400 million common stock offering.
  • Trio-Tech International TRT shares fell 14% to close at $10.70.
  • Armstrong Flooring, Inc. AFI fell 13.7% to close at $2.39. Armstrong Flooring shares climbed around 40% on Monday after the company said it is exploring a sale of the business.
  • Equillium, Inc. EQ dropped 13.3% to settle at $3.60. Equillium’s Phase 1b EQUIP study of itolizumab in patients with uncontrolled asthma met its primary objective.
  • Global-e Online Ltd. GLBE shares fell 13.2% to close at $55.01.
  • Dada Nexus Limited DADA fell 13.1% to close at $11.45. Shares of Chinese companies traded lower in reaction to new Chinese cybersecurity rules from February 15.
  • Pear Therapeutics, Inc. PEAR shares fell 12.2% to close at $6.70. BTIG, on Monday, initiated coverage on the stock with a Buy rating and announced a $12 price target.
  • Abcam plc ABCM shares dipped 9% to close at $21.75. Alamar Biosciences and Abcam reported a strategic partnership to further understanding of the human proteome.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasIntegrated Telecommunication ServicesMovers From YesterdayTelecommunication ServicesTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...